• 10 results in Exploration of Neuroprotective Therapy
    Sort by
    Latest
    Open Access
    Perspective
    Maternal imprinting, mitochondrial DNA, nuclear DNA and Alzheimer’s disease
    Familial early-onset Alzheimer's disease (AD) is more probable in individuals coming from mothers diagnosed with AD than from fathers diagnosed with AD. Studies in animal models have show...
    Alberto Pérez-Mediavilla, Marta Zamarbide
    Published: October 29, 2021 Explor Neuroprot Ther. 2021;1:121-126
    DOI: https://doi.org/10.37349/ent.2021.00010
    View:162
    Download:19
    Times Cited: 0
    Open Access
    Review
    Immunization with neural-derived peptides as a neuroprotective therapy for spinal cord injury
    Spinal cord injury (SCI) induces several destructive events that develop immediately after the primary insult. These phenomena increase tissue damage; that is why, numerous therapeutic approaches ar...
    Andrea Paola Ibarra-García, Antonio Ibarra
    Published: October 29, 2021 Explor Neuroprot Ther. 2021;1:111-120
    DOI: https://doi.org/10.37349/ent.2021.00009
    View:221
    Download:24
    Times Cited: 0
    Open Access
    Review
    Striking a balance: PIP2 and PIP3 signaling in neuronal health and disease
    Phosphoinositides are membrane phospholipids involved in a variety of cellular processes like growth, development, metabolism, and transport. This review focuses on the maintenance of cellular homeo...
    Kamran Tariq, Bryan W. Luikart
    Published: October 29, 2021 Explor Neuroprot Ther. 2021;1:86-110
    DOI: https://doi.org/10.37349/ent.2021.00008
    This article belongs to the special issue Cholesterol Dyshomeostasis in Neurological Diseases
    View:303
    Download:21
    Times Cited: 0
    Open Access
    Review
    T-cell based immunotherapies for Parkinson’s disease
    Current evidence indicates that neurodegeneration of dopaminergic neurons of the substantia nigra associated to Parkinson's disease is a consequence of a neuroinflammatory process in whic...
    Rodrigo Pacheco
    Published: October 29, 2021 Explor Neuroprot Ther. 2021;1:72-85
    DOI: https://doi.org/10.37349/ent.2021.00007
    View:240
    Download:11
    Times Cited: 0
    Open Access
    Review
    Therapeutic potential of the cannabinoid receptor 2 in neuropsychiatry
    Since the identification and cloning of the cannabinoid receptor 2 (CB2R), several studies focused on the characterization of its physiological and pathological role. Initially, CB2R was considered ...
    María S. García-Gutiérrez ... Jorge Manzanares
    Published: August 05, 2021 Explor Neuroprot Ther. 2021;1:55-71
    DOI: https://doi.org/10.37349/ent.2021.00006
    View:512
    Download:32
    Times Cited: 0
    Open Access
    Review
    Gut microbial imbalance and neurodegenerative proteinopathies: from molecular mechanisms to prospects of clinical applications
    The pathogenic basis behind some of the most prevalent neurodegenerative diseases in advanced societies, known as proteinopathies, deals with alterations in protein homeostasis. Despite the broad di...
    Paula Alonso-García ... Eva Martínez-Pinilla
    Published: August 05, 2021 Explor Neuroprot Ther. 2021;1:33-54
    DOI: https://doi.org/10.37349/ent.2021.00005
    View:629
    Download:44
    Times Cited: 0
    Open Access
    Review
    Neurological complications during HIV infection
    Early in the course of infection, human immunodeficiency virus (HIV) is able to enter the central nervous system where it stablishes a permanent reservoir. Current antiretroviral therapies do not ef...
    Jose M. Martinez-Navio
    Published: August 05, 2021 Explor Neuroprot Ther. 2021;1:19-32
    DOI: https://doi.org/10.37349/ent.2021.00004
    View:668
    Download:69
    Open Access
    Review
    Cholesterol in autism spectrum disorders
    The autism spectrum disorder (ASD) comprises a series of neurological diseases that share serious alterations of the development of the central nervous system. The degree of disability may vary so t...
    Rafael Franco ... Irene Reyes-Resina
    Published: August 05, 2021 Explor Neuroprot Ther. 2021;1:10-18
    DOI: https://doi.org/10.37349/ent.2021.00003
    This article belongs to the special issue Cholesterol Dyshomeostasis in Neurological Diseases
    View:832
    Download:62
    Times Cited: 0
    Open Access
    Letter to the Editor
    P2X7 receptor involvement in COVID-19 disease
    Peter Illes
    Published: August 05, 2021 Explor Neuroprot Ther. 2021;1:7-9
    DOI: https://doi.org/10.37349/ent.2021.00002
    View:336
    Download:24
    Times Cited: 0
    Open Access
    Editorial
    Science plus technology to address challenges in determining the efficacy of neuroprotective/neurorestorative therapies
    Rafael Franco
    Published: August 05, 2021 Explor Neuroprot Ther. 2021;1:1-6
    DOI: https://doi.org/10.37349/ent.2021.00001
    View:892
    Download:21
    Times Cited: 0